Pentoxifylline reduces blood viscosity, mostly in capillaries. Как следствие – улучшаются снабжение тканей кислородом и приток крови.
Agapurine is used:
In the first week of treatment, the initial dose for adults is 200 mg pentoxifylline, taking the drug three times a day. Patients with chronic diseases, usually take 100 mg pentoxifylline three times a day. In case of hypotension, negative reactions from the central nervous system or gastrointestinal tract, starting dose may be reduced to 100 mg pentoxifylline three times a day. Patients with renal impairment are advised to reduce the dose by 50 – 70% from normal dose, creatine level> 400 mmol / l.
The maximum daily dose is 1200 mg and should not be exceeded.
Dragee should be taken whole, better at the same time during meals or after. Drink some liquid.
Nausea may occur in case of drug overdose., dizziness, tachycardia or low blood pressure. Symptoms not excluded, including fever, tides, excitation, loss of consciousness.
In case of overdose, stop taking the drug, wash out the stomach, take activated charcoal. In order to prevent complications in acute overdose, general and specialized medical supervision is required..
Agapurin is generally well tolerated., but sometimes there may be such side reactions: tachycardia, gipotenziya, symptoms of angina pectoris, arrhythmia, bleeding in various organs, gipoglikemiâ. Possible nausea, vomiting and a feeling of fullness in the stomach. Headache not ruled out, nervousness, excitation, bad dream, high perspiration. Sometimes there is hypersensitivity (hives, rash, itch), but allergic manifestations disappear after the termination or termination of treatment.
Agapurin is contraindicated in:
With caution, the drug should be prescribed to patients with such cardiac arrhythmias., acute myocardial infarction, with severe hepatic dysfunction, patients at risk of overdose and adverse reactions and hypotension. Patients with hemorrhagic diathesis also require caution..
Pentoxifylline enhances the effect of antihypertensive and other vasodilators, which can cause severe hypotension. A significant decrease in blood pressure is possible when used simultaneously with adrenergic and ganglionic blockers. Simultaneous use of xanthines or adrenergic substances leads to stimulation of the central nervous system.. Higher doses of pentoxifylline potentiate the effect of oral hypoglycemic agents and insulin. With time, recommended adjustment of antidiabetic therapy due to risk of hypoglycemia. Blood glucose levels are recommended to be measured more frequently. The incidence of complications of hemorrhage is increased in patients, who are being treated concomitantly with anticoagulants, thrombolytic and antiplatelet agents. In these patients, prothrombin time should be measured more frequently..
Structure:
IN 1 dragee contains pentoxifylline 100 mg. Excipients: lactose,corn starch, talc, magnesium stearate, colloidal silicon dioxide, carmellose sodium, mottled sucrose, powdered sucrose, acacia, titanium dioxide.
Drop.
due to inhibition of the phosphodiesterase enzyme, Pentoxifylline relaxes the smooth muscles of the arterioles., followed by accumulation of cyclic AMP. Pentoxifylline reduces blood viscosity, mostly in capillaries. Как следствие – улучшаются снабжение тканей кислородом и приток крови. It inhibits platelet adhesion and aggregation. Pentoxifylline increases the elasticity and flexibility of red blood cells, increases the concentration of ATP in the external environment. Pentoxifylline has cytoprotective and anti-inflammatory effects, based on a decrease in the activation of neutrophils and a decrease in the synthesis of macrophage cytokines. These properties can be used in the treatment of sepsis, bronchial asthma and endotoxic shock.
Keep away from children. The storage temperature should not exceed 25 ° C.
Срок хранения – 5 years.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More